Both in Pharmaceuticals
Minerva Neurosciences vs Immunic
Over the past year NERV returned −30.0% and IMUX returned +14.9%; their daily moves had a correlation of 0.04.
NERV −30.0% IMUX +14.9%Growth of $1, one year, split-adjusted
| Metric | NERV | IMUX |
|---|---|---|
| Price | $2.57 | $7.94 |
| Market cap | $122.7M | $108.3M |
| Today | +9.36% | +4.47% |
| 1 month | −25.1% | +1.5% |
| 6 months | −58.7% | −27.9% |
| Year to date | −36.1% | +48.8% |
| 1 year | −32.7% | +6.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $75.3M | $155.1M |
| Dividend yield | — | — |
| Volatility (60d) | 79.8% | 73.5% |
| Short % of float | 6.0% | 17.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).